No-Spa Injection 40mg IV/IM
Rs. 1399
Availability: In Stock
Marketed By: Sanofi Aventis
Therapeutic Segment: Anti-spasmodic
Generic: Drotaverine
Indication:
No-Spa® (Drotaverine HCI) is used as an antispasmodic in the management of biliary-tract, urinary-tract, and gastrointestinal spasm. No-Spa® is indicated in the management of irritable bowel syndrome, renal colic, biliary colic, and the management of severe pain during menstruation.
Product Form: Injection IM/IV 40mg